Chromatography Resin Market to Reach USD 3.5 Billion by 2031, Says Stratview Research

The global chromatography resin market was estimated at USD 3.1 billion in 2024 and is projected to reach USD 3.5 billion by 2031, growing at a CAGR of 1.3% during 2024-2031. Chromatography resins are specialized stationary-phase materials used in chromatography processes to separate, purify, and isolate biomolecules and chemicals across pharmaceutical, biotechnology, and research applications. The most significant growth driver for the market is the rapid expansion of the biopharmaceutical industry, as increasing production of monoclonal antibodies, biologics, biosimilars, and vaccines is driving demand for highly efficient purification technologies that can meet stringent regulatory purity standards.

Stratview Research, a global market research firm, has launched a report on the global market, which provides a comprehensive outlook of the global and regional industry forecast, current & emerging market trends, segment analysis, competitive landscape, & more.

Request a free sample report: https://www.stratviewresearch.com/Request-Sample/chromatography-resin-market#form

Market Statistics

• Market size: USD 3.1 billion in 2024
• Forecast value: USD 3.5 billion by 2031
• CAGR: 1.3%
• Forecast period: 2024-2031
• Base year: 2023
• Total number of segments: 5
• Tables & figures: 100+
• Country-Level Market Assessment: 20

Market Segmentation

By Technique Type
Affinity Resins
Mixed-Mode Resins
Ion-Exchange Resins
Other Techniques

By Product Type
Natural Resins
Synthetic Resins
Inorganic Resins

By System Type
Single-Use Systems
Multi-Use Systems

By End-Use Industry Type
Pharmaceutical
Biotechnology
Academic
Chemicals
Environmental Testing
CROs (Contract Research Organizations)
Government Research
Hospitals & Clinical Trials
Agricultural
Food & Beverages
Other Industries

By Region
North America [The USA, Canada, and Mexico]
Europe [Germany, France, The UK, and Rest of Europe]
Asia-Pacific [China, Japan, India, and Rest of Asia-Pacific]
Rest of the World [Latin America, the Middle East and Others]

Segment Analysis

Based on technique type, affinity resins are expected to remain the dominant segment throughout the forecast period due to their superior specificity and efficiency in purifying biomolecules such as monoclonal antibodies, recombinant proteins, and therapeutic compounds. These resins use biological interaction mechanisms including antigen-antibody and receptor-ligand binding to selectively isolate target molecules from complex mixtures, reducing purification steps while improving yield and product quality. Mixed-mode resins are projected to register the fastest growth because they combine multiple interaction modes such as ionic and hydrophobic interactions, enabling greater flexibility and improved impurity removal in advanced bioprocessing applications. This trend is encouraging manufacturers to invest in more versatile purification platforms that support continuous manufacturing and high-throughput processing.

By product type, natural resins are projected to hold the largest market share owing to their high biocompatibility, excellent porosity, and established use in bioseparation applications. Agarose- and cellulose-based resins continue to be widely adopted in affinity and ion-exchange chromatography for purifying proteins, antibodies, and nucleic acids. Synthetic resins are expected to witness the fastest growth due to their enhanced chemical and mechanical stability, enabling them to withstand harsh operating conditions and support continuous chromatography systems. As demand rises for next-generation biologics and complex molecules, suppliers are increasingly focusing on engineered synthetic materials with improved performance characteristics.

Based on system type, multi-use systems are anticipated to dominate the market because of their cost efficiency and extensive adoption in large-scale biopharmaceutical manufacturing facilities. These systems enable repeated resin usage across multiple batches, lowering the overall purification cost in high-throughput production environments. Single-use systems are projected to grow at a faster pace due to increasing demand for flexible, scalable, and contamination-free bioprocessing solutions suitable for clinical trials and small-to-mid-scale manufacturing. The growing shift toward personalized medicine and modular manufacturing facilities is creating new growth opportunities for companies offering disposable purification technologies.

In terms of end-use industry type, the pharmaceutical segment is expected to account for the largest market share during the forecast period. Chromatography resins play a critical role in downstream bioprocessing for biologics, vaccines, recombinant proteins, and monoclonal antibodies, making them essential to pharmaceutical manufacturing workflows. Rising incidences of chronic diseases, aging populations, and increased investment in personalized medicine are further accelerating demand for high-purity purification systems. The pharmaceutical sector's continued focus on regulatory compliance and advanced drug manufacturing is strengthening long-term demand for reliable chromatography solutions across commercial-scale production facilities.

Regional Insights

North America is expected to maintain its dominant position in the chromatography resin market throughout the forecast period due to its strong biopharmaceutical manufacturing base, advanced research infrastructure, and high concentration of leading pharmaceutical and biotechnology companies. The region continues to benefit from substantial investment in biologics development, increasing clinical trial activity, and the presence of major chromatography resin manufacturers and life sciences technology providers. Continued innovation in purification technologies and strong regulatory support are reinforcing the region's leadership in large-scale bioprocessing applications.

Asia-Pacific is projected to witness the fastest market growth during the forecast period, driven by rapid expansion in pharmaceutical and biotechnology manufacturing capabilities and increasing investments in research and development. Countries including China, India, South Korea, and Japan are strengthening their biomanufacturing ecosystems to address both domestic healthcare demand and global outsourcing opportunities. Rising activity among contract development and manufacturing organizations, combined with lower production costs and supportive government initiatives, is accelerating adoption of chromatography-based purification systems across the region.

Market Drivers

• Rapid growth in the biopharmaceutical industry is increasing demand for chromatography resins for purification of monoclonal antibodies, vaccines, and recombinant proteins.

• Stringent regulatory standards from agencies such as the FDA and EMA are pushing pharmaceutical manufacturers to adopt high-performance purification technologies to ensure product safety and purity.

• Increasing investment in biologics and biosimilars manufacturing is driving the need for scalable downstream bioprocessing solutions with higher purification efficiency.

• Growing adoption of single-use bioprocessing systems is supporting demand for flexible and contamination-free chromatography purification workflows in clinical and contract manufacturing environments.

• Expansion of continuous manufacturing and high-throughput bioprocessing technologies is increasing the need for advanced resin materials capable of improving selectivity, yield, and productivity.

Competitive Landscape
Top Companies in the Market
Danaher Corporation
Merck Group
Thermo Fisher Scientific Inc.
Sartorius AG
Agilent Technologies, Inc.
Avantor Performance Materials, Inc.
Bio-Rad Laboratories, Inc.
Bio-Works Technologies AB
Merck KGaA
Mitsubishi Chemical Corporation
Purolite Corporation
Sartorius Stedim Biotech S.A.
Tosoh Corporation

FAQs

How big is the chromatography resin market expected to become by 2031?
The chromatography resin market is projected to reach USD 3.5 billion by 2031, growing at a CAGR of 1.3% during 2024-2031.

Why are pharmaceutical companies investing heavily in chromatography resins?
Pharmaceutical companies rely on chromatography resins for high-purity separation and purification of biologics, monoclonal antibodies, vaccines, and recombinant proteins during downstream bioprocessing.

Which chromatography resin segment is seeing the fastest growth?
Mixed-mode resins are projected to witness the fastest growth due to their ability to combine multiple interaction mechanisms and improve purification efficiency in advanced bioprocessing applications.

Which region is creating the strongest growth opportunities for chromatography resin suppliers?
Asia-Pacific is expected to register the fastest market growth because of rising biopharmaceutical manufacturing investments, expanding CDMO activity, and increasing demand for biologics production.

Who are the leading companies operating in the chromatography resin market?
Key companies operating in the market include Danaher Corporation, Merck Group, Thermo Fisher Scientific Inc., Sartorius AG, Agilent Technologies, Inc., Avantor Performance Materials, Inc., Bio-Rad Laboratories, Inc., Mitsubishi Chemical Corporation, Purolite Corporation, and Tosoh Corporation.

Contact Us:

400 Renaissance Center, Suite 2600,
Detroit, Michigan, MI 48243
United States of America

Website: www.stratviewresearch.com
Mail Us: sales@stratviewresearch.com
Press: media@stratviewresearch.com

About Us:
Stratview Research is a global market research firm that highly specializes in aerospace & defense, chemicals, and a few other industries.

It launches a limited number of reports annually on the above-mentioned specializations. Thorough analysis and accurate forecasts in this report enable the readers to take convincing business decisions.

Stratview Research has been helping companies meet their global and regional growth objectives by offering customized research services. These include market assessment, due diligence, opportunity screening, voice of customer analysis, market entry strategies, and more.

This release was published on openPR.